Hall of Fame player Dwyane Wade says doctors performed a December 2023 surgery on his kidney to remove a tumor later ...

Dwayne Wade opens up on *The Why with Dwayne Wade* podcast about a personal health battle that began with seemingly routine symptoms.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a ...

Chronic kidney disease (CKD) is a growing global health concern, significantly contributing to morbidity and mortality rates worldwide. Characterized by a ...

Research highlights the survival benefits of non-drug blood pressure control in dialysis patients with CKD. Ultrafiltration proves more effective than antihypertensives for long-term outcomes.

According to the National Kidney Foundation, 123,000 Americans are on that waitlist. More than a 100,000 of those waiting ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

The approval is based on results from the Phase III FLOW trial demonstrating Ozempic reduced the risk of severe kidney outcomes by 24% compared to placebo, including kidney failure, reduction in ...